Page 11 - Healio Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Healio coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Healio Coverage Today - Breaking & Trending Today

Top in ID: Hospital cuts infections by 80%; US reports locally acquired malaria cases

Top in ID: Hospital cuts infections by 80%; US reports locally acquired malaria cases
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United States , Katie Palladino , Melinda Gates Foundation , University Of Pittsburgh Medical Center Mercy , Healio Coverage , Pittsburgh Medical Center Mercy ,

Top in cardiology: Effects of vitamin D; new details on man's death after xenotransplant

Top in cardiology: Effects of vitamin D; new details on man's death after xenotransplant
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Joanne Manson , Healio Coverage ,

Top in allergy/asthma: Epinephrine spray action date; COVID-19 vaccine safety finding

The FDA has set a new target action date for ARS Pharmaceuticals’ neffy epinephrine nasal spray, which is designed to treat anaphylaxis and other type 1 allergic reactions without a needle or injection. The new action date has been extended to Sept. 19. ....

Richard Lowenthal , Pharmaceuticals To Sept , Journal Of The European Academy Dermatology , Healio Coverage , European Academy ,

Top in women's health: Supplements fall short; portable ultrasound device shows promise

Out of more than 20,000 dietary supplements, only one had sufficient nutrients in required doses that pregnant patients need, according to a study recently published in The American Journal of Clinical Nutrition. Researchers found that the supplement that contained target doses for six important nutrients was more expensive and required more tablets per serving. It was the top story in ....

United States , Healio Coverage , American Journal ,

Top in cardiology: FDA OKs gout drug to reduce CV events; studies support SGLT2 inhibitors

A 0.5 mg dose of colchicine, a drug commonly used for conditions such as gout, was recently approved by the FDA to prevent cardiovascular events in patients with residual inflammatory risk.It is the first anti-inflammatory agent to be approved as an atheroprotective CV treatment, according to a press release from the manufacturer, and is expected to be available later this year. News of the ....

Agepha Pharma , Jagmeetp Singh , Journal Of The American College Cardiology , Healio Coverage , American College , Damar Hamlin , Cardiology Today Editorial Board Member Jagmeet ,